Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist. (Q52195685)

26 April 2018

title

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist. (English)

1 reference

26 April 2018

author name string

Mansbach RS

series ordinal

1

1 reference

26 April 2018

Brooks EN

series ordinal

2

1 reference

26 April 2018

Chen YL

series ordinal

3

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 March 1997

1 reference

26 April 2018

European Journal of Pharmacology

published in

1 reference

26 April 2018

volume

323

1 reference

26 April 2018

issue

1

1 reference

26 April 2018

page(s)

21-26

1 reference

26 April 2018

Hypothalamic-pituitary-adrenal axis and suicide

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Stress, antidepressant drugs, and the locus coeruleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Blunted Corticotropin and Normal Cortisol Response to Human Corticotropin-Releasing Factor in Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Chronic imipramine treatment induces downregulation of alpha-2 receptors in rat's locus coeruleus and A2 region of the tractus solitarius

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

The role of corticotropin-releasing factor in behavioural responses to stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Desmethylimipramine (DMI) counteracts learned helplessness in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Learned helplessness: Theory and evidence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotropin-releasing factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Learned helplessness sensitizes hippocampal norepinephrine to mild restress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Specificity of the learned helplessness model of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Reversal of learned helplessness by nortriptyline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Corticotropin-releasing factor: evidence for a neurotransmitter role in the locus ceruleus during hemodynamic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

The validity of animal models of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900025-3

10.1016/S0014-2999(97)00025-3

7 January 2021

Identifiers

DOI

1 reference

26 April 2018

PubMed ID

9105872

1 reference

26 April 2018